A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer

Clinical trial NCT07585279 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07585279
Sponsor: Hebei Medical University Fourth Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (CRC)Liposomal Irinotecan Second-Line

Start date: 2026-05-20
Primary completion: 2031-02-28
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.